Zota Health Care Ltd
ZOTAZota Health Care Ltd
ZOTA
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -43.19 | 16.65 | 0.17% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 50.26 | 6.38 | 0.53% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Zota Health Care Ltd. is a pharmaceutical company engaged in the business of manufacturing and marketing of medicines
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Mankind Pharma Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 87.10 | 96.59 | 109.08 | 132.82 | 142.45 | 181.65 | 221.31 | |||||||
Raw Materials | 64.27 | 59.57 | 75.88 | 86.67 | 99.41 | 108.83 | 220.43 | |||||||
| Power & Fuel Cost | 0.54 | 0.60 | 0.70 | 0.89 | 1.27 | 2.18 | ||||||||
| Employee Cost | 8.02 | 9.59 | 8.58 | 9.52 | 12.19 | 29.33 | ||||||||
| Selling & Administrative Expenses | 10.19 | 11.80 | 21.47 | 17.25 | 34.55 | 41.47 | ||||||||
| Operating & Other expenses | -5.20 | 9.01 | -0.46 | 2.06 | -14.79 | -8.88 | ||||||||
EBITDA | 9.28 | 6.02 | 2.91 | 16.43 | 9.82 | 8.72 | 0.88 | |||||||
| Depreciation/Amortization | 1.39 | 2.10 | 3.17 | 3.67 | 11.96 | 20.09 | 29.41 | |||||||
| PBIT | 7.89 | 3.92 | -0.26 | 12.76 | -2.14 | -11.37 | -28.53 | |||||||
| Interest & Other Items | 0.04 | 0.07 | 0.11 | 0.32 | 2.56 | 4.79 | 8.57 | |||||||
| PBT | 7.85 | 3.85 | -0.37 | 12.44 | -4.70 | -16.16 | -37.10 | |||||||
| Taxes & Other Items | 2.31 | 1.12 | -0.15 | 3.53 | 1.08 | -1.81 | -2.42 | |||||||
| Net Income | 5.54 | 2.73 | -0.22 | 8.91 | -5.78 | -14.35 | -34.68 | |||||||
| EPS | 1.61 | 0.93 | -0.09 | 3.58 | -2.30 | -5.63 | -13.42 | |||||||
| DPS | 0.71 | 1.00 | 1.00 | 1.50 | 1.00 | 1.00 | 1.00 | |||||||
| Payout ratio | 0.44 | 1.08 | — | 0.42 | — | — | -0.07 |
Company Updates
Investor Presentation
Investor Presentation
Investor Presentation
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Zota Health Care Ltd | -104.37 | 16.65 | 0.17% |
| Sun Pharmaceutical Industries Ltd | 44.98 | 6.42 | 0.75% |
| Cipla Ltd | 29.13 | 4.48 | 0.87% |
| Torrent Pharmaceuticals Ltd | 64.71 | 15.63 | 0.88% |
Price Comparison
Compare ZOTA with any stock or ETFShareholdings
Promoter Holdings Trend
Decreased Total Promoter Holding
In last 6 months, promoter holding in the company has decreased by 3.75%
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Apr 2024
Jun 2024
Aug 2024
Sep 2024
Shareholding History
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividend Cuts
ZOTA has increased or maintained dividend levels over the last 5 years
Dividend Yield
Current dividend yield is 0.17%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹1.73 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 20, 2024
Dividend/Share
₹1.00
Ex DateEx Date
Sep 20, 2024
Cash Dividend
Ex DateEx DateSep 22, 2023
Dividend/Share
₹1.00
Ex DateEx Date
Sep 22, 2023
Cash Dividend
Ex DateEx DateSep 19, 2022
Dividend/Share
₹1.50
Ex DateEx Date
Sep 19, 2022
Cash Dividend
Ex DateEx DateSep 22, 2021
Dividend/Share
₹1.00
Ex DateEx Date
Sep 22, 2021
Cash Dividend
Ex DateEx DateSep 17, 2020
Dividend/Share
₹1.00
Ex DateEx Date
Sep 17, 2020
Net Loss of Zota Health Care reported to Rs 12.10 crore in the quarter ended September 2024 as against net loss of Rs 1.65 crore during the previous quarter ended September 2023. Sales rose 48.62% to Rs 67.28 crore in the quarter ended September 2024 as against Rs 45.27 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales67.2845.27 49 OPM %-1.299.76 - PBDT-3.183.69 PL PBT-12.69-1.11 -1043 NP-12.10-1.65 -633 Powered by Capital Market - Live
Zota Health Care will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
Zota Health Care announced that the 24th Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live
Net Loss of Zota Health Care reported to Rs 12.72 crore in the quarter ended June 2024 as against net loss of Rs 2.84 crore during the previous quarter ended June 2023. Sales rose 45.67% to Rs 56.30 crore in the quarter ended June 2024 as against Rs 38.65 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales56.3038.65 46 OPM %-2.243.31 - PBDT-4.140.60 PL PBT-12.16-2.81 -333 NP-12.72-2.84 -348 Powered by Capital Market - Live
Zota Health Care will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live
Zota Health Care consolidated net profit declines 71.65% in the September 2022 quarter
Zota Health Care reports consolidated net loss of Rs 0.82 crore in the June 2022 quarter
Zota Healthcare’s ‘Corovyl’ successfully clears second phase of clinical study; Stock up 2.5%
Zota Health Care standalone net profit rises 225.49% in the September 2021 quarter
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 15.84%, vs industry avg of 9.03%
Increasing Market Share
Over the last 5 years, market share increased from 0.04% to 0.05%